Items where authors include "Picarda, G."
Article
Redini, F., Odri, G.A., Picarda, G. et al. (4 more authors) (2013) Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? Expert Opinion on Emerging Drugs, 18 (3). pp. 339-352. ISSN 1472-8214
Picarda, G., Matous, E., Amiaud, J. et al. (8 more authors) (2013) Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL. Journal of Bone Oncology, 2 (3). pp. 95-104. ISSN 2212-1374
Talbot, J., Brion, R., Picarda, G. et al. (8 more authors) (2013) Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832 (4). pp. 553-564. ISSN 0925-4439
Picarda, G., Surget, S., Guiho, R. et al. (7 more authors) (2012) A Functional, New Short Isoform of Death Receptor 4 in Ewing's Sarcoma Cell Lines May be Involved in TRAIL Sensitivity/Resistance Mechanisms. Molecular Cancer Research, 10 (3). pp. 336-346. ISSN 1541-7786
Picarda, G., Trichet, V., Teletchea, S. et al. (2 more authors) (2012) TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment. American Journal of Cancer Research, 2 (1). pp. 45-64. ISSN 2156-6976
Battaglia, S., Dumoucel, S., Chesneau, J. et al. (6 more authors) (2011) Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient. Journal of Bone and Mineral Research, 26 (10). pp. 2439-2451. ISSN 0884-0431
Odri, G.A., Dumoucel, S., Picarda, G. et al. (10 more authors) (2010) Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research, 70 (19). pp. 7610-7619. ISSN 0008-5472
Rousseau, J., Escriou, V., Perrot, P. et al. (6 more authors) (2010) Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Therapy , 17 (6). pp. 387-397. ISSN 0929-1903
Picarda, G., Lamoureux, F., Geffroy, L. et al. (7 more authors) (2010) Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival. Clinical Cancer Research, 16 (8). pp. 2363-2374. ISSN 1078-0432
Lamoureux, F., Picarda, G., Garrigue-Antar, L. et al. (7 more authors) (2009) Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma. Cancer Research, 69 (2). pp. 526-536. ISSN 0008-5472
Lamoureux, F., Picarda, G., Rousseau, J. et al. (6 more authors) (2008) Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Molecular Cancer Therapeutics, 7 (10). pp. 3389-3398. ISSN 1535-7163